Company intelligence / Profile preview

Recombinators

Ownership: Private
Development stage: Other

Overview

Recombinators is a strategy and innovation consultancy specializing in solving complex business challenges for clients in the pharmaceutical, life sciences, and healthcare sectors. The firm leverages its proprietary Precedent-Driven Innovation (PDI) approach to help clients with brand positioning, market access strategies, growth initiatives, and defending legacy brands against competition. It works with global pharmaceutical companies to address issues such as product launches in saturated markets and salesforce effectiveness.

Industry: Consulting

Partnerships

Not specified by name but has worked with "some of the world's most iconic organizations and brands" within pharma/life sciences sectors

Beyond the preview

Go deeper on Recombinators.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recombinators.

Explore the full profile